Abstract | BACKGROUND: METHODS AND RESULTS: To examine the physiological role of H(mox-1), a line of heterozygous H(mox-1)-knockout mice was developed by targeted disruption of the mouse H(mox-1) gene. Transgene integration was confirmed and characterized at the protein level. A 40% reduction of H(mox-1) protein occurred in the hearts of H(mox-1)(+/)(-) mice compared with those of wild-type mice. Isolated mouse hearts from H(mox-1)(+/)(-) mice and wild-type controls perfused via the Langendorff mode were subjected to 30 minutes of ischemia followed by 120 minutes of reperfusion. The H(mox-1)(+/)(-) hearts displayed reduced ventricular recovery, increased creatine kinase release, and increased infarct size compared with those of wild-type controls, indicating that these H(mox-1)(+/)(-) hearts were more susceptible to ischemia/reperfusion injury than wild-type controls. These results also suggest that H(mox-1)(+/)(-) hearts are subjected to increased amounts of oxidative stress. Treatment with 2 different antioxidants, Trolox or N:-acetylcysteine, only partially rescued the H(mox-1)(+/)(-) hearts from ischemia/reperfusion injury. Preconditioning, which renders the heart tolerant to subsequent lethal ischemia/reperfusion, failed to adapt the hearts of the H(mox-1)(+/)(-) mice compared with wild-type hearts. CONCLUSIONS: These results demonstrate that H(mox-1) plays a crucial role in ischemia/reperfusion injury not only by functioning as an intracellular antioxidant but also by inducing its own expression under stressful conditions such as preconditioning.
|
Authors | T Yoshida, N Maulik, Y S Ho, J Alam, D K Das |
Journal | Circulation
(Circulation)
Vol. 103
Issue 12
Pg. 1695-701
(Mar 27 2001)
ISSN: 1524-4539 [Electronic] United States |
PMID | 11273999
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antioxidants
- Chromans
- Membrane Proteins
- Malondialdehyde
- 1,3-dimethylthiourea
- Heme Oxygenase (Decyclizing)
- Heme Oxygenase-1
- Hmox1 protein, mouse
- Creatine Kinase
- Thiourea
- 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
- Acetylcysteine
|
Topics |
- Acetylcysteine
(pharmacology)
- Animals
- Antioxidants
(pharmacology)
- Chromans
(pharmacology)
- Creatine Kinase
(metabolism)
- Disease Models, Animal
- Gene Targeting
- Heart
(drug effects)
- Heart Rate
(drug effects, genetics)
- Heme Oxygenase (Decyclizing)
(genetics, metabolism)
- Heme Oxygenase-1
- Heterozygote
- In Vitro Techniques
- Ischemic Preconditioning, Myocardial
- Malondialdehyde
(metabolism)
- Membrane Proteins
- Mice
- Mice, Transgenic
- Myocardial Contraction
(drug effects, genetics)
- Myocardial Infarction
(diet therapy, genetics, pathology, prevention & control)
- Myocardial Ischemia
(enzymology, genetics)
- Myocardium
(metabolism)
- Reperfusion Injury
(enzymology, genetics, pathology, prevention & control)
- Thiourea
(analogs & derivatives, pharmacology)
|